Amicare Sp z o.o. S.K.
- Address
- Ul. Partyzantow 1A, 26-300 Opoczno, Poland
Amicare Sp z o.o. S.K.
Amicare Sp z o.o. S.K. is a specialized clinical research center focused on advancing treatments for gastrointestinal disorders. The center demonstrates expertise in conducting therapeutic trials for chronic inflammatory conditions affecting the digestive system, with particular emphasis on evaluating novel oral medications for patients requiring advanced treatment options.
- Moderate to severe ulcerative colitis treatment research
- Clinical activity assessment of investigational oral therapies
- Safety evaluation in inflammatory bowel disease populations
The center's research initiatives concentrate on ulcerative colitis, a chronic inflammatory condition of the colon and rectum. Amicare contributes to the development of innovative therapeutic approaches by conducting rigorous clinical trials that evaluate both the efficacy and safety profiles of new pharmaceutical agents, helping to expand treatment options for patients with difficult-to-manage gastrointestinal conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Amicare Sp z o.o. S.K.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Oral 1,3,5-Tris(6-Methylpyridin-2-yloxy)benzene in Moderate to Severe Ulcerative Colitis: A Phase 2 Randomized Controlled Trial | Landos Biopharma Inc. | Phase II | Not Recruiting | Dec 2023 | Apr 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 1,3,5-Tris(6-Methylpyridin-2-Yloxy)Benzene | 1 | Unknown | 2023-12-04 | 2023-12-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.